Anritsu Corporation is pleased to announce the submission of the industry’s first Protocol Conformance test in the Sub-6 GHz Frequency Range 1 (FR1) to 3GPP RAN5 working group for approval. The test defined by 3GPP TS38.523 has been verified with Exynos modem 5100 5G New Radio (NR) modem developed by Samsung’s System LSI Business on Anritsu ME7834NR Protocol Conformance test system.
The ME7834NR Protocol Conformance test Platform is registered with both the Global Certification Forum (GCF) and PCS Type Certification Review Board (PTCRB) as Test Platform (TP) 251.
“Anritsu continues to support our leading edge technology development by providing quick access to latest features on their test solutions.” said Mr. Woonhaing Hur, Vice President of System LSI Protocol Development at Samsung Electronics “5G is evolving at a much faster pace than previous technologies, and I am pleased to see that Anritsu is keeping ahead of the evolution as they did during LTE-Advanced and LTE-Advanced Pro.
“We are proud that Samsung continue to rely on our test solutions.” said Mr. Tsutomu Tokuke, General Manager of Anritsu’s Mobile Solutions Division “Our collaboration with Samsung has helped us achieve yet another important industry milestone in the journey towards 5G NR commercialization.”
The ME7834NR is a test platform for 3GPP-based Protocol Conformance Test (PCT) and Carrier Acceptance Testing (CAT) of mobile devices incorporating Multiple Radio Access Technologies (RAT). It supports 5G NR in both Standalone (SA) and Non-Standalone (NSA) mode, in addition to LTE, LTE-Advanced (LTE-A), LTE-A Pro, and W-CDMA. When combined with Anritsu’s new OTA chamber MA8171A and RF converters, the ME7834NR covers the sub-6 GHz and millimeter wave (mmWave) 5G frequency bands.
Tower Semiconductor announced that it has signed silicon photonics agreements valued at $1.3 billion for…
The report is based on a survey of 150 CISOs and senior cybersecurity leaders from…
More than 200,000 voters will cast ballots using a secure and cryptographically verified online voting…
The multi-center study, involving 2,000 patients, will validate the CORA system - a breakthrough AI…
Molex, a global electronics leader and connectivity innovator, has completed the acquisition of Teramount Ltd.,…
This agreement marks the third expansion of its collaboration with AstraZeneca, building on collaborations in…